SCHEMBL29640749

SCHEMBL29640749

O=C1CCCN1c1ccc(F)nc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
AKR1C3 P42330 5/20 0.49
HPGD P15428 4/20 0.44
HRH3 Q9Y5N1 2/20 0.44
HRH1 P35367 1/20 0.44
MEN1 O00255 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
HTR6 P50406 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31035634 0.81 ALDH1A1 (0.51) ALDH1A1AKR1C3HPGDHRH3HRH1
SCHEMBL1269266 0.81 ALDH1A1 (0.51) ALDH1A1AKR1C3HPGDHRH3HRH1
SCHEMBL1727049 0.80 AKR1C3 (0.52) ALDH1A1AKR1C3HPGDHRH3KMT2A
SCHEMBL30088471 0.80 ALDH1A1 (0.50) ALDH1A1AKR1C3HPGDHRH3HRH1
SCHEMBL30731050 0.80 ALDH1A1 (0.50) ALDH1A1AKR1C3HPGDHRH3HRH1
SCHEMBL23832364 0.80 ALDH1A1 (0.50) ALDH1A1AKR1C3HPGDHRH3HRH1
SCHEMBL3605010 0.80 ALDH1A1 (0.50) ALDH1A1AKR1C3HPGDHRH3HRH1
SCHEMBL25184171 0.79 KMT2A (0.50) ALDH1A1AKR1C3MEN1KMT2ALMNA
SCHEMBL11142367 0.78 ALDH1A1 (0.74) ALDH1A1AKR1C3HPGDTSHRCYP1A2
SCHEMBL13456031 0.78 ALDH1A1 (0.47) ALDH1A1AKR1C3HPGDHRH3HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320213-A1 Nitrogen-Containing Heterocyclic Compounds PFIZER INC. (US) 2025-10-16 US disclosed
WO-2025215579-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS PFIZER INC. (US) 2025-10-16 WO disclosed
CN-112218857-B P300/CBP HAT inhibitors and methods of use thereof 星座制药公司 2023-11-21 CN disclosed
CN-114450005-A Compounds for the treatment of neurological disorders 星座制药公司 2022-05-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320213-A1 Nitrogen-Containing Heterocyclic Compounds HRH4, HNMT, NNT ALDH1A1 2633/4885AKR1C3 553/4885HPGD 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.